Bianble Biotech Registers Patent for Ozone-Reducing Plasma Skincare Device
Genolution's subsidiary Bianble Biotech has registered a patent for a plasma skincare device incorporating ozone-reduction technology.
According to Bianble Biotech on November 18, the patent covers technology that draws in and purifies ozone inside the device before it can spread outside during the operation of a personal plasma beauty device. Bianble Biotech developed a proprietary intake structure that draws outside air into the device the moment it comes into contact with the skin, directing the ozone to a purification filter for removal.
The technology is already being used in products from Bianble Biotech's premium beauty brand, "Angbeul Ppeuritti." According to the company's test data, the product's ozone emission concentration was measured at 0.000219 ppm. This is only about 0.44% of the U.S. Food and Drug Administration's (FDA) maximum allowable ozone emission level of 0.05 ppm.
Bianble Biotech plans to strengthen its brand presence in the existing business-to-consumer (B2C) home beauty market and expand into the business-to-business (B2B) market, targeting professional skincare institutions and other organizations. Having secured an original patent for a skin treatment device, the company also plans to gradually assess the possibility of entering the medical device market by further developing related technologies and products.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Bianble Biotech representative said, "We will support the subsidiary in establishing a foundation for growth by strengthening product competitiveness and expanding distribution channels, and contribute to diversifying Genolution's business portfolio."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.